Approval · Notice of Compliance 4590 · 1996
ZOFRAN: Notice of Compliance 4590
Issued March 7, 1996
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4590
- Date
- March 7, 1996
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiemetic (5-ht3 receptor antagonist)
Products in this notice
Medicinal ingredients
- ODANSETRON HCL 4 MG per TAB
- ODANSETRON HCL 8 MG per TAB
- ODANSETRON HCL 2 MG per ML